Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
63.6M
-
Number of holders
-
184
-
Total shares
-
44.8M
-
Shares change
-
+54K
-
Total reported value, excl. options
-
$3.5B
-
Value change
-
+$28.7M
-
Put/Call ratio
-
1.7
-
Number of buys
-
95
-
Number of sells
-
-87
-
Price
-
$78.06
Significant Holders of Blueprint Medicines Corp - Common Stock (BPMC) as of Q3 2018
192 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock as of Q3 2018.
Blueprint Medicines Corp - Common Stock (BPMC) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.8M shares
of 63.6M outstanding shares and own 70.37% of the company stock.
Largest 10 shareholders include FMR LLC (6.58M shares), Vanguard Group Inc (3.74M shares), BlackRock Inc. (3.45M shares), WELLINGTON MANAGEMENT GROUP LLP (2.94M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.88M shares), STATE STREET CORP (1.69M shares), OppenheimerFunds, Inc. (1.67M shares), Partner Fund Management, L.P. (1.44M shares), Hillhouse Capital Management, Ltd. (1.43M shares), and TimesSquare Capital Management, LLC (1.04M shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.